Preparing for the inevitable next pandemic
In the 21st century, viral spillovers will become more and more common. We are not in the dark and can prepare now for new breakouts before they even begin.
Infectious Disease & Vaccines
Drug-resistant gonorrhea is no match for a new class of antibiotics
New inhibitors specific for gonorrhea enzymes may pave the way to treating multi-drug resistant infections.
Understanding Plant-Based Vaccines
Plants offer several unique advantages for accelerated vaccine production.
Lipoproteins hide Lyme bacteria from the immune system
Scientists identified two proteins that help Lyme bacteria evade detection by the human complement system, paving the way for new therapeutics and vaccine targets.
A new compound targets bacteria hiding in biofilms
A bacterial inhibitor enhances conventional antibiotics by killing Staphylococcus aureus and stopping a communication system in Pseudomonas aeruginosa.
Developing CRISPR Biosensors
CRISPR biosensing technology provides unambiguous pathogen detection.
Synthetic Biology for Accelerated Vaccine Discovery
Automated synthetic biology workflows enable efficient mRNA-based therapeutic development.
Science comedy gets to the heart of science communication
Using comedy to talk about technical topics makes science more accessible.
Genetic discrimination and Snapchat
What do 23andMe and Snapchat have in common? They both collect very personal information about their users. Do the benefits outweigh the risks?
An antimalarial drug targets bacterial infections
Antibiotic resistance is on the rise and scientists are on the lookout for new therapeutics for treating human pathogens. One promising new venture repurposes antimalarial drugs to treat patients with chronic lung diseases such as cystic fibrosis.
